Arcadia Investment Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $345K | Sell |
5,000
-1,354
| -21% | -$93.5K | 0.06% | 98 |
|
|
2025
Q1 | $441K | Buy |
6,354
+2,000
| +46% | +$139K | 0.08% | 94 |
|
|
2024
Q4 | $375K | Buy |
4,354
+1,000
| +30% | +$86K | 0.06% | 99 |
|
|
2024
Q3 | $399K | Hold |
3,354
| – | – | 0.07% | 97 |
|
|
2024
Q2 | $479K | Hold |
3,354
| – | – | 0.08% | 87 |
|
|
2024
Q1 | $431K | Hold |
3,354
| – | – | 0.08% | 91 |
|
|
2023
Q4 | $347K | Hold |
3,354
| – | – | 0.07% | 99 |
|
|
2023
Q3 | $305K | Hold |
3,354
| – | – | 0.06% | 105 |
|
|
2023
Q2 | $271K | Buy |
3,354
+1,354
| +68% | +$110K | 0.06% | 115 |
|
|
2023
Q1 | $159K | Hold |
2,000
| – | – | 0.03% | 147 |
|
|
2022
Q4 | $135K | Buy |
+2,000
| New | +$135K | 0.03% | 157 |
|
|
2017
Q3 | – | Sell |
-170
| Closed | -$4K | – | 384 |
|
|
2017
Q2 | $4K | Hold |
170
| – | – | ﹤0.01% | 349 |
|
|
2017
Q1 | $3K | Hold |
170
| – | – | ﹤0.01% | 415 |
|
|
2016
Q4 | $3K | Hold |
170
| – | – | ﹤0.01% | 309 |
|
|
2016
Q3 | $4K | Sell |
170
-56
| -25% | -$1.32K | ﹤0.01% | 318 |
|
|
2016
Q2 | $6K | Sell |
226
-748
| -77% | -$19.9K | ﹤0.01% | 423 |
|
|
2016
Q1 | $26K | Buy |
974
+170
| +21% | +$4.54K | 0.01% | 201 |
|
|
2015
Q4 | $23K | Buy |
+804
| New | +$23K | 0.01% | 210 |
|